David Hsieh

David Hsieh

University of Texas Southwestern - Dallas / United States
Others
AD Scientific Index ID: 1679875
University of Texas Southwestern Medical Center
person_outline David Hsieh's MOST POPULAR ARTICLES
1-) Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label …S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ...The Lancet 402 (10415), 1835-1847, 2023962023
2-) Political partisanship and mobility restriction during the COVID-19 pandemicD Hsiehchen, M Espinoza, P SlovicPublic health 187, 111-114, 2020902020
3-) Multinational teams and diseconomies of scale in collaborative researchD Hsiehchen, M Espinoza, A HsiehScience Advances 1 (8), e1500211, 2015812015
4-) DNA repair gene mutations as predictors of immune checkpoint inhibitor response beyond tumor mutation burdenD Hsiehchen, A Hsieh, RM Samstein, T Lu, MS Beg, DE Gerber, T Wang, ...Cell reports medicine 1 (3), 2020722020
5-) Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint InhibitorsD Hsiehchen, MK Watters, R Lu, Y Xie, DE GerberJAMA Network Open 2 (9), e1911519-e1911519, 2019702019